MoneyWorks4Me

The sales figure stood at Rs. 965.76 millions for the September 2023 quarter. The mentioned figure indicates a growth of about 25.14% as compared to Rs. 771.77 millions during the year-ago period.Good  Net Profit growth of 34.97% reported above the corresponding previous quarter figure of Rs. 136.16 millions to Rs. 183.78 millioins.Operating Profit saw a handsome growth to 274.03 millions from 209.46 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 965.76 771.77 25.14 1819.25 1492.87 21.86 3115.29 2727.98 14.20
Other Income 7.85 20.00 -60.75 520.34 32.45 1503.51 98.08 90.80 8.02
PBIDT 274.03 209.46 30.83 1034.29 336.59 207.28 846.96 817.28 3.63
Interest 0.33 0.26 26.92 0.68 0.54 25.93 1.35 0.95 42.11
PBDT 273.70 209.20 30.83 1033.61 336.05 207.58 845.61 816.33 3.59
Depreciation 26.09 25.07 4.07 51.16 49.16 4.07 102.83 95.61 7.55
PBT 247.61 184.13 34.48 982.45 286.89 242.45 742.78 720.72 3.06
TAX 63.83 47.97 33.06 123.80 72.95 69.71 187.51 175.61 6.78
Deferred Tax -2.32 0.77 -401.30 -3.00 -0.31 867.74 4.97 -4.56 -208.99
PAT 183.78 136.16 34.97 858.65 213.94 301.35 555.27 545.11 1.86
Equity 223.65 223.64 0.00 223.65 223.64 0.00 223.65 223.60 0.02
PBIDTM(%) 28.37 27.14 4.55 56.85 22.55 152.16 27.19 29.96 -9.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..